Subtle Symptoms Mask Serious Lung Disease

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that causes progressive scarring of lung tissue, making breathing increasingly difficult. Often mistaken for common ailments such as acid reflux or a persistent cough, IPF symptoms can be subtle and develop gradually. This gradual onset means the condition may go undiagnosed for months or even years, with patients sometimes misdiagnosed with pneumonia.

IPF affects approximately 50,000 Americans annually, typically older adults in their 60s and 70s, with men being more commonly affected. Smoking is a significant risk factor, and a family history of IPF also increases susceptibility. Early detection and treatment are crucial, as they can help slow the disease's progression.

Fortunately, advancements in treatment offer hope. Three FDA-approved antifibrotic medications, including the recently approved nerandomilast (Jascayd), are available to slow the loss of lung function. Additionally, comprehensive treatment plans may include pulmonary rehabilitation to improve lung capacity and supplemental oxygen therapy for those experiencing shortness of breath.